Comprehensive Study on the Quality of Life in Cervical Cancer Patients

Concentration of follicle-stimulating hormone

Follicle-stimulating hormone tested in peripheral blood

Time frame: Change from the baseline of four weeks before major therapy at following-up

Concentration of estradiol

Estradiol tested in peripheral blood

Time frame: Change from the baseline of four weeks before major therapy at following-up

Concentration of anti-mullerian hormone

Anti-mullerian hormone tested in peripheral blood

Time frame: Change from the baseline of four weeks before major therapy at following-up

Concentration of inhibin B

Inhibin B tested in peripheral blood

Time frame: Change from the baseline of four weeks before major therapy at following-up

Bladder capacity at the first void sense

Bladder capacity at the first void sense tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Bladder capacity at normal desire to void

Bladder capacity at normal desire to void tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Bladder capacity at strong desire to void

Bladder capacity at strong desire to void tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Maximun flow rate

Maximun flow rate tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Average flow rate

Average flow rate tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Bladder pressure at maximun flow rate

Bladder pressure at maximun flow rate tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Detrusor pressure at maximun flow rate

Detrusor pressure at maximun flow rate tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Bladder compliance at strong desire to void

Bladder compliance at strong desire to void tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Detrusor compliance at strong desire to void

Detrusor compliance at strong desire to void tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Residual urine volume

Residual urine volume tested by urodynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up

Anal sphincter pressure

Anal sphincter pressure tested by rectum dynamic testing

Time frame: Change from the baseline of four weeks before major therapy at following-up